The five healthy volunteers who recently took part in clinical drug trials and sufferred terrible side-effects as a result of the trial were being tested for the treatment of leukaemia and auto-immune and inflammatory diseases.

However mother nature has already provided a naturally occurring, physiological agent with no inhibitory effects called Serrapeptase.

Serrapeptase is an enzyme which was originally discovered in the intestine of the silkworm and used for escaping from its cocoon.

Today it is naturally processed through fermentation and made readily available in supplement form.

Serrapeptase digests non-living tissue, blood clots, cysts, and arterial plaque and inflammation in all forms.

Inflammation in the body is normally an important mechanism for protecting it from attack by invading organisms, faulty cells and trauma. However, when the immune system becomes dysfunctional, it loses its ability to differentiate between innocuous and potentially dangerous substances. This dysfunction results in a wide array of diseases such as rheumatoid arthritis, ulcerative colitis, allergies, psoriasis, uveitis, multiple sclerosis and some forms of cancer.

In spite of the huge range of successful enzyme studies showing safety and effectiveness, the standard therapy for inflammatory-mediated diseases and trauma include drugs such as steroids and non-steroidal anti-inflammatory agents (NSAIDs). These classes of drugs do in most cases offer temporary, symptomatic relief from swelling, inflammation and accompanying pain, but without treating the underlying condition.

Serratia peptidase (Serrapeptase) was discovered in the early 1970’s and is now in wide clinical use throughout Europe and Asia as a viable alternative to drugs. It has no inhibitory effects on prostaglandins, is devoid of gastrointestinal side effects and offers a sensible alternative to drugs and medication.

Only Enteric coated Serrapeptase tablets have been subject to the research showing excellent results. Capsules (which may not pass the stomach acid) are unlikely to be as effective unless the granules inside the capsule are enteric coated and contain 40,000iu of activity.